about
Clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatologySwitching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician.A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeability.A practical guide about biosimilar data for health care providers treating inflammatory diseasesInsights on the use of biosimilars in the treatment of inflammatory bowel disease.Biosimilars in psoriasis: Clinical practice and regulatory perspectives in Latin America.Characterization and non-clinical assessment of the proposed etanercept biosimilar GP2015 with originator etanercept (Enbrel(®)).Biosimilars in Inflammatory Bowel Disease - Accumulating Clinical Evidence.Biosimilars in rheumatology: recommendations for regulation and use in Middle Eastern countries.The process defines the product: what really matters in biosimilar design and production?A randomized phase I comparative pharmacokinetic study comparing SB5 with reference adalimumab in healthy volunteers.Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.The biosimilars journey: current status and ongoing challenges
P2860
Q26766028-5CA9DC1D-C35A-4272-9CCC-CBD2CFEEE2FBQ33840949-76B6D5B1-231F-4B85-82D1-2DDD5F49FC42Q33881234-78D56FB7-E317-4A14-86DA-136C821C05D6Q36303459-8570DBB9-1122-40A9-B693-68CC1CF84013Q38735477-FF6D1C6E-6C1B-48CE-9BCF-38774BB33EA8Q38800156-37506A74-CE95-4E4B-8CF9-71B7BED56B59Q38910179-F6CC5C0B-DBE1-44BB-B154-9E22FE081B18Q39016810-07C1C7C8-17AD-49AD-89AF-85367BC0DCD8Q50108062-89D41AB0-0FFE-4456-85D5-B65B9F623CF1Q50115805-61E8CFC9-D1BD-4545-8DF6-E35BBBE4D7F1Q50546879-9772D793-E089-4BF9-BCFA-B7F5A33DCD65Q55283747-F2E7C671-BD33-46DE-A731-63830FF5C39FQ57298628-D3E673D3-7941-4246-BD60-D2EFCB08C86E
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Clinical trial development for biosimilars
@ast
Clinical trial development for biosimilars
@en
Clinical trial development for biosimilars
@nl
type
label
Clinical trial development for biosimilars
@ast
Clinical trial development for biosimilars
@en
Clinical trial development for biosimilars
@nl
prefLabel
Clinical trial development for biosimilars
@ast
Clinical trial development for biosimilars
@en
Clinical trial development for biosimilars
@nl
P1476
Clinical trial development for biosimilars
@en
P2093
Rieke Alten
P356
10.1016/J.SEMARTHRIT.2015.04.002
P407
P433
P577
2015-06-01T00:00:00Z